Joan Cox Gill

Summary

Affiliation: Blood Research Institute
Country: USA

Publications

  1. ncbi Treatment of urgent bleeding in von Willebrand disease
    Joan Cox Gill
    Medical College of Wisconsin, Blood Center of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Thromb Res 120:S21-5. 2007
  2. ncbi von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
    J C Gill
    Comprehensive Center for Bleeding Disorders, Blood Center of Wisconsin, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Haemophilia 17:895-905. 2011
  3. ncbi VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population
    Daniel B Bellissimo
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI, USA
    Blood 119:2135-40. 2012
  4. ncbi Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD
    Veronica H Flood
    Department of Pediatrics, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Blood 117:e67-74. 2011
  5. ncbi Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
    Sandra L Haberichter
    Department of Pediatrics Hematology Oncology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA
    Blood 108:3344-51. 2006
  6. ncbi Von Willebrand disease in the United States: a perspective from Wisconsin
    Veronica H Flood
    Division of Hematology Oncology, Department of Pediatrics, Medical College of Wisconsin, Wisconsin 53201 2178, USA
    Semin Thromb Hemost 37:528-34. 2011
  7. ncbi Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage
    Paula M Jacobi
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53201, USA
    Blood 119:4543-53. 2012
  8. ncbi Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor
    Veronica H Flood
    Department of Pediatrics, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI 53201, USA
    Blood 116:280-6. 2010
  9. ncbi Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis
    Justin K Kakela
    BloodCenter of Wisconsin, 638 N 18th Street, P O Box 2178, Milwaukee, WI 53201, USA
    Mol Genet Metab 87:262-71. 2006
  10. ncbi Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease
    Joan Cox Gill
    Blood Center of Southeastern Wisconsin, Medical College of Wisconsin, Milwaukee, 53201-2178, USA
    J Pediatr 140:595-9. 2002

Collaborators

Detail Information

Publications11

  1. ncbi Treatment of urgent bleeding in von Willebrand disease
    Joan Cox Gill
    Medical College of Wisconsin, Blood Center of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Thromb Res 120:S21-5. 2007
    ..In this article, specific approaches to the choice of treatment modalities, calculation of dosages, monitoring of therapy, possible side effects and complications of the treatment of the various types of VWD will be discussed...
  2. ncbi von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
    J C Gill
    Comprehensive Center for Bleeding Disorders, Blood Center of Wisconsin, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Haemophilia 17:895-905. 2011
    ..The results indicate that this VWF/FVIII concentrate is safe and effective in the prevention of excessive bleeding during and after surgery in individuals with VWD...
  3. ncbi VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population
    Daniel B Bellissimo
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI, USA
    Blood 119:2135-40. 2012
    ..This study emphasizes the importance of sequencing healthy controls to understand ethnic-specific sequence variations so that asymptomatic sequence variations are not misidentified as mutations in other ethnic or racial groups...
  4. ncbi Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD
    Veronica H Flood
    Department of Pediatrics, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Blood 117:e67-74. 2011
    ..The VWF:IbCo ELISA, however, was not affected by D1472H. The VWF:IbCo ELISA may be useful in testing VWF binding to GPIb, discrimination of type 2 variants, and in the diagnosis of VWD as it avoids some of the pitfalls of VWF:RCo assays...
  5. ncbi Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
    Sandra L Haberichter
    Department of Pediatrics Hematology Oncology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA
    Blood 108:3344-51. 2006
    ..This phenotype may require an altered clinical therapeutic approach, and we propose to refer to this phenotype as type-1C VWD...
  6. ncbi Von Willebrand disease in the United States: a perspective from Wisconsin
    Veronica H Flood
    Division of Hematology Oncology, Department of Pediatrics, Medical College of Wisconsin, Wisconsin 53201 2178, USA
    Semin Thromb Hemost 37:528-34. 2011
    ..Results so far have shown that VWF gene polymorphisms are common, particularly in African Americans, and may affect laboratory assays of VWF function...
  7. ncbi Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage
    Paula M Jacobi
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53201, USA
    Blood 119:4543-53. 2012
    ....
  8. ncbi Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor
    Veronica H Flood
    Department of Pediatrics, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI 53201, USA
    Blood 116:280-6. 2010
    ..Because the VWF:RCo assay depends on ristocetin binding to VWF, mutations (and polymorphisms) in VWF may affect the measurement of "VWF activity" by this assay and may not reflect a functional defect or true hemorrhagic risk...
  9. ncbi Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis
    Justin K Kakela
    BloodCenter of Wisconsin, 638 N 18th Street, P O Box 2178, Milwaukee, WI 53201, USA
    Mol Genet Metab 87:262-71. 2006
    ..This DHPLC and DNA sequencing technique will enable the full length assessment of the VWF gene necessary to detect mutations causing types 1 and 3 VWD...
  10. ncbi Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease
    Joan Cox Gill
    Blood Center of Southeastern Wisconsin, Medical College of Wisconsin, Milwaukee, 53201-2178, USA
    J Pediatr 140:595-9. 2002
    ..CONCLUSION: We conclude that administration of 150 microg of high concentration intranasal desmopressin is safe and effective in patients weighing < or = 50 kg with mild hemophilia A or mild type 1 VWD...
  11. ncbi Preventing excessive bleeding in patients with von Willebrand disease
    Joan Cox Gill
    Clin Adv Hematol Oncol 4:207-9. 2006